135 related articles for article (PubMed ID: 35691363)
1. Kinase Inhibition by PKC412 Prevents Epithelial Sheet Damage in Autosomal Dominant Epidermolysis Bullosa Simplex through Keratin and Cell Contact Stabilization.
Rietscher K; Jahnke HG; Rübsam M; Lin EW; Has C; Omary MB; Niessen CM; Magin TM
J Invest Dermatol; 2022 Dec; 142(12):3282-3293. PubMed ID: 35691363
[TBL] [Abstract][Full Text] [Related]
2. A Drosophila Model of Epidermolysis Bullosa Simplex.
Bohnekamp J; Cryderman DE; Paululat A; Baccam GC; Wallrath LL; Magin TM
J Invest Dermatol; 2015 Aug; 135(8):2031-2039. PubMed ID: 25830653
[TBL] [Abstract][Full Text] [Related]
3. Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, a Useful Model to Identify and Explore the Pathological Phenotype of Epidermolysis Bullosa Simplex.
Coutier J; Bonnette M; Martineau S; Mercadier A; Domingues S; Saidani M; Jarrige M; Polveche H; Darle A; Holic N; Hadj-Rabia S; Bodemer C; Lemaitre G; Martinat C; Baldeschi C
J Invest Dermatol; 2022 Oct; 142(10):2695-2705.e11. PubMed ID: 35490743
[TBL] [Abstract][Full Text] [Related]
4. Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.
Evtushenko NA; Beilin AK; Kosykh AV; Vorotelyak EA; Gurskaya NG
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830328
[TBL] [Abstract][Full Text] [Related]
5. Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.
Homberg M; Ramms L; Schwarz N; Dreissen G; Leube RE; Merkel R; Hoffmann B; Magin TM
J Invest Dermatol; 2015 Oct; 135(10):2437-2445. PubMed ID: 25961909
[TBL] [Abstract][Full Text] [Related]
6. Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition.
Chamcheu JC; Lorié EP; Akgul B; Bannbers E; Virtanen M; Gammon L; Moustakas A; Navsaria H; Vahlquist A; Törmä H
J Dermatol Sci; 2009 Mar; 53(3):198-206. PubMed ID: 19157792
[TBL] [Abstract][Full Text] [Related]
7. A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex.
Tan TS; Common JEA; Lim JSY; Badowski C; Firdaus MJ; Leonardi SS; Lane EB
J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34643242
[TBL] [Abstract][Full Text] [Related]
8. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations.
Rugg EL; Horn HM; Smith FJ; Wilson NJ; Hill AJ; Magee GJ; Shemanko CS; Baty DU; Tidman MJ; Lane EB
J Invest Dermatol; 2007 Mar; 127(3):574-80. PubMed ID: 17039244
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations.
Morley SM; D'Alessandro M; Sexton C; Rugg EL; Navsaria H; Shemanko CS; Huber M; Hohl D; Heagerty AI; Leigh IM; Lane EB
Br J Dermatol; 2003 Jul; 149(1):46-58. PubMed ID: 12890194
[TBL] [Abstract][Full Text] [Related]
10. In silico analysis of all point mutations on the 2B domain of K5/K14 causing epidermolysis bullosa simplex: a genotype-phenotype correlation.
Banerjee S; Wu Q; Yu P; Qi M; Li C
Mol Biosyst; 2014 Oct; 10(10):2567-77. PubMed ID: 25017986
[TBL] [Abstract][Full Text] [Related]
11. Functional testing of keratin 14 mutant proteins associated with the three major subtypes of epidermolysis bullosa simplex.
Sørensen CB; Andresen BS; Jensen UB; Jensen TG; Jensen PK; Gregersen N; Bolund L
Exp Dermatol; 2003 Aug; 12(4):472-9. PubMed ID: 12930305
[TBL] [Abstract][Full Text] [Related]
12. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients.
Bolling MC; Lemmink HH; Jansen GH; Jonkman MF
Br J Dermatol; 2011 Mar; 164(3):637-44. PubMed ID: 21375516
[TBL] [Abstract][Full Text] [Related]
13. Keratin gene mutations influence the keratinocyte response to DNA damage and cytokine induced apoptosis.
Zupancic T; Sersa G; Törmä H; Lane EB; Herrmann H; Komel R; Liovic M
Arch Dermatol Res; 2017 Sep; 309(7):587-593. PubMed ID: 28647894
[TBL] [Abstract][Full Text] [Related]
14. ERK involvement in resistance to apoptosis in keratinocytes with mutant keratin.
Russell D; Ross H; Lane EB
J Invest Dermatol; 2010 Mar; 130(3):671-81. PubMed ID: 19847192
[TBL] [Abstract][Full Text] [Related]
15. Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex.
Roth W; Reuter U; Wohlenberg C; Bruckner-Tuderman L; Magin TM
Hum Mutat; 2009 May; 30(5):832-41. PubMed ID: 19267394
[TBL] [Abstract][Full Text] [Related]
16. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.
Morley SM; Dundas SR; James JL; Gupta T; Brown RA; Sexton CJ; Navsaria HA; Leigh IM; Lane EB
J Cell Sci; 1995 Nov; 108 ( Pt 11)():3463-71. PubMed ID: 8586658
[TBL] [Abstract][Full Text] [Related]
17. Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability.
Sawant M; Schwarz N; Windoffer R; Magin TM; Krieger J; Mücke N; Obara B; Jankowski V; Jankowski J; Wally V; Lettner T; Leube RE
J Invest Dermatol; 2018 Mar; 138(3):627-636. PubMed ID: 29080682
[TBL] [Abstract][Full Text] [Related]
18. Disease-associated keratin mutations reduce traction forces and compromise adhesion and collective migration.
Fujiwara S; Deguchi S; Magin TM
J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32616561
[TBL] [Abstract][Full Text] [Related]
19. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein.
Chan Y; Anton-Lamprecht I; Yu QC; Jäckel A; Zabel B; Ernst JP; Fuchs E
Genes Dev; 1994 Nov; 8(21):2574-87. PubMed ID: 7525408
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis on 16 Japanese population cases with epidermolysis bullosa simplex.
Minakawa S; Nakano H; Nakajima K; Matsuzaki Y; Takiyoshi N; Akasaka E; Rokunohe D; Sawamura D
J Dermatol Sci; 2013 Dec; 72(3):330-2. PubMed ID: 23993914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
